Pays: Tunisie
Langue: français
Source: Ministère de la Santé, Direction de l'inspection Pharmaceutique
La CARBAMAZÉPINE
Dar Al Dawa Development and Investment Co.Ltd
CARBAMAZEPINE
200 MG
Comprimé
B/30
C
ANTI-EPILEPTIQUES
SYSTEME NERVEUX
- GRAND-MAL ASSOCIE OU NON A DES TROUBLES PSYCHIQUES. - EPILEPSIE PARTIELLE, EN PARTICULER EPILEPSIE PSYCHOMOTRICE DU LOBE TEMPORAL. - EPILEPSIE AVEC ATTEINTE PSYCHIQUE PREDOMINANTE. - TROUBLES CARACTERIELS INTERCRITIQUES. - TRAITEMENT DES NEVRALGIES FACIALES - PREVENTION DES RECHUTES MANIACODEPRESSIVES DANS LE CADRE DES PSYCHOSES MANIACODEPRESSIVES. - TRAITEMENT DES ETATS D'EXCITATION MANIAQUE.
Classement VEIC: Vital
2002-01-24
DESCRIPTION: CARBATOL ® (carbamazepine) is an anticonvulsant agent. Inactive Ingredients: Microcrystalline cellulose, silica colloidal anhydrous, sodium starch glycolate, magnesium stearate, sodium laurilsulfate. PHARMACOLOGY: The mechanism of action of carbamazepine, the active substance of CARBATOL ® , has not yet been fully elucidated. Carbamazepine stabilizes hyperexcited nerve membranes, inhibits repetitive neuronal discharges and reduces synaptic propagation of excitatory impulses. It is conceivable that inhibition of repetitive firing sodium dependent action potentials in depolarized neurons via use and voltage- dependent blockade of sodium channels may be its main mechanism of action. Whereas reduction of glutamate release and stabilization of neuronal membranes may account mainly for the antiepileptic activity of carbamazepine, the inhibitory effect on dopamine and noradrenaline turnover may be responsible for its antimanic properties. INDICATIONS: Epilepsy - Partial seizures (simple or complex, with or without loss of consciousness), with or without secondary generalization. - Generalized tonic-clonic seizures. - Mixed forms of these seizures. CARBATOL ® is suitable for both monotherapy and combination therapy. CARBATOL ® is not normally effective in absence (petit mal) or in myoclonic seizures. Acute mania and maintenance treatment of bipolar affective disorders to prevent or attenuate recurrence. Alcohol-withdrawal syndrome. Idiopathic trigeminal neuralgia and trigeminal neuralgia secondary to multiple sclerosis (typical or atypical). Idiopathic glossopharyngeal neuralgia. CONTRAINDICATIONS: Known hypersensitivity to carbamazepine and oxcarbazepine or structurally related drugs (e.g. tricyclic antidepressants), or to any of the other components of the formulation. Atrioventricular (AV) block, history of bone-marrow depression or history of acute intermittent porphyria. On the basis of its structural similarity to tricyclic antidepressants, use of CARBATOL ® in combination with monoamino-oxidase i Lire le document complet